Article
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
Blood - 21 Dec 2017
Heimall Jennifer, Logan Brent R, Cowan Morton J, Notarangelo Luigi D, Griffith Linda M, Puck Jennifer M, Kohn Donald B, Pulsipher Michael A, Parikh Suhag, Martinez Caridad, Kapoor Neena, O'Reilly Richard, Boyer Michael, Pai Sung-Yun, Goldman Frederick, Burroughs Lauri, Chandra Sharat, Kletzel Morris, Thakar Monica, Connelly James, Cuvelier Geoff, Davila Saldana Blachy J, Shereck Evan, Knutsen Alan, Sullivan Kathleen E, DeSantes Kenneth, Gillio Alfred, Haddad Elie, Petrovic Aleksandra, Quigg Troy, Smith Angela R, Stenger Elizabeth, Yin Ziyan, Shearer William T, Fleisher Thomas, Buckley Rebecca H, Dvorak Christopher C
Abstract excerpt
The Primary Immune Deficiency Treatment Consortium (PIDTC) is enrolling children with severe combined immunodeficiency (SCID) to a prospective natural history study. We analyzed patients treated with allogeneic hematopoietic cell transplantation (HCT) from 2010 to 2014, including 68 patients with typical SCID and 32 with leaky SCID, Omenn syndrome, or reticular dysgenesis. Most (59%) patients were diagnosed by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
